People channel feed

Ex­clu­sive: Aviv Regev talks three years of lead­ing Genen­tech’s re­search, the fu­ture of AI, and not mak­ing No­bel pre­dic­tions

24 minutes ago
R&D
AI

Bris­tol My­ers’ lead deal ne­go­tia­tor to de­part af­ter ink­ing se­ries of multi­bil­lion-dol­lar ac­qui­si­tions

2 days ago
Pharma

Three big win­ners from Ab­b­Vie's $8.7B Cerev­el deal: A drug­mak­er, a CEO and a SPAC

3 days ago
Deals
Pharma

NASH drug­mak­er He­p­i­on to seek strate­gic al­ter­na­tives

4 days ago
Pharma

IGM Bio­sciences cuts 22% of work­force, ax­es hema­to­log­ic on­col­o­gy pro­gram

5 days ago
R&D

Scoop: Res­o­nance Med­i­cine, a pro­tease biotech from David Liu’s lab, shuts down

5 days ago
Startups

BIO names its vice chair and Am­i­cus founder John Crow­ley as next CEO

6 days ago

Tra­vere plans to lay off 20% of work­force as it fo­cus­es on full ap­proval for kid­ney dis­ease drug

6 days ago

An­oth­er Flag­ship-found­ed biotech shut­ters as Ax­cel­la liq­ui­dates, end­ing long Covid plans

6 days ago
R&D

Or­na Ther­a­peu­tics trims staff in ‘de­fen­sive re­duc­tion’ de­spite large fi­nanc­ing hauls

Last week
Startups
Cell/Gene Tx

Gilead­'s cell ther­a­py busi­ness Kite cuts 7% of work­force

Last week
Cell/Gene Tx

Gen­er­a­tion Bio to lay off 68 em­ploy­ees in a dif­fi­cult year for non-vi­ral gene ther­a­py biotechs

Last week
Cell/Gene Tx

Eli Lil­ly’s Dan Skovron­sky on oral GLP-1, ‘slow­er ramp’ for Alzheimer’s and deals on ‘un­der­ap­pre­ci­at­ed’ as­sets

Last week
R&D

Novo­cure to lay off 200 work­ers, nar­row pipeline for elec­tric fields can­cer ther­a­py

Last week
R&D

For­mer Terns CEO Senthil Sun­daram pass­es away fol­low­ing bat­tle with can­cer

Last week

Ex­clu­sive: Ae­glea re­brands to Spyre, names new CEO in IBD race against TL1A drugs at Mer­ck, Roche and Sanofi

2 weeks ago

Flag­ship-found­ed Evelo Bio­sciences will dis­solve af­ter find­ing no 'vi­able al­ter­na­tive'

3 weeks ago
R&D

Bernie Sanders in­vites CEOs of J&J, Mer­ck, Bris­tol My­ers to tes­ti­fy on drug pric­ing

3 weeks ago
Pharma
FDA+

Q&A with Ju­dith Ng-Cashin, CRO Novotech's chief med­ical of­fi­cer, on 2023 and be­yond

4 weeks ago

Biden taps Van­der­bilt’s Kim­ryn Rath­mell to suc­ceed Bertag­nol­li as the NI­H's can­cer chief

4 weeks ago
Pharma
FDA+

FDA's Janet Wood­cock to re­tire in ear­ly 2024

4 weeks ago
FDA+

Heard at #Jef­feries23: Al­ny­lam, Bi­cy­cle, In­tel­lia, Nous­com, Rakuten Med­ical ex­ecs fore­cast 2024

4 weeks ago
Pharma

Three months af­ter big re­or­ga­ni­za­tion, an­ti­body mak­er Atre­ca is back with an­oth­er round of lay­offs

4 weeks ago

Pfiz­er to cut 500 jobs at Sand­wich, UK site

4 weeks ago
Pharma
1234 Next page Last page
A service from the Financial Times